BioSpace News Archive

Concept Companies, a national commercial real estate developer specializing in turnkey projects, announces the commencement of the design and construction of a new 11,961-square-foot laboratory facility for Lacerta Therapeutics, Inc., a gene therapy company.

Viral Clearance Market size was USD 403.5 Million in 2020 and is expected to register a CAGR of 21.9% during the forecast period.

Trauma Products Market size was USD 5.01 Billion in 2020 and is expected to register a revenue CAGR of 8.1% during the forecast period.

PetDx® – The Liquid Biopsy Company for Pets™ is participating in the Stifel 2022 Jaws & Paws Conference taking place in New York City on Wednesday, June 1, 2022.

Exicure, Inc., an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, announced that the Company’s Annual Meeting of Stockholders held in virtual format on Friday, May 27, 2022 at 1:00 p.m.

Ambrx Biopharma Inc., or Ambrx, a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics, announced that Feng Tian, Ph.D., Chairman of the Board, President and CEO of Ambrx, will participate in two upcoming investor conferences in June.

The report consists of quantitative and qualitative research on the market performed by our market experts.

City of Hope, one of the largest cancer research and treatment organizations in the United States, announced it would present research on promising treatments for bladder and blood cancers, as well as studies on precision medicine and an experimental cancer vaccine, at the 2022 American Society of Clinical Oncology’s annual conference from June 3 to 7 in Chicago.

Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula on U.S. store shelves in the coming weeks and months.

ObsEva SA announced that it has entered into a waiver and amendment agreement with respect to its amended and restated securities purchase agreement with certain funds and accounts managed by JGB Management, Inc., which is structured to provide up to $135 million in borrowing capacity, available in nine tranches.